Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients
Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients
复制标题
索磷布韦和达拉他韦治疗肾移植受者的慢性丙型肝炎病毒感染
DOI:
10.1111/tid.13018
复制
发表时间:
2018-11
影响因子:
2.6
通讯作者:
Jianghua Chen
中科院分区:
文献类型:
--
作者:
Hongfeng Huang;Huanna Tang;Hao Deng;Jia Shen;Qin Zhou;Wenqing Xie;Jianyong Wu;Jianghua Chen
To assess the efficacy and the risk of sofosbuvir‐daclatasvir treatment among kidney transplant recipients (KTRs) with chronic hepatitis C virus (HCV) infection.
登录
查看更多内容
影响因子:
4.2
作者:
Wen-Chin Lee;K. Shu;Chi-hung Cheng;Ming-Ju Wu;Cheng-Hsu Chen;J. Lian
通讯作者:
Wen-Chin Lee;K. Shu;Chi-hung Cheng;Ming-Ju Wu;Cheng-Hsu Chen;J. Lian
影响因子:
25.7
作者:
C. Schüttler;Nicola Fiedler;K. Schmidt;R. Repp;W. Gerlich;S. Schaefer
通讯作者:
C. Schüttler;Nicola Fiedler;K. Schmidt;R. Repp;W. Gerlich;S. Schaefer
影响因子:
0.9
作者:
Gentil, M. A.;Gonzalez-Corvillo, C.;Sanchez-Fructuoso, A.
通讯作者:
Sanchez-Fructuoso, A.
影响因子:
25.7
作者:
Fernandez, Inmaculada;Munoz-Gomez, Raquel;Londono, Maria-Carlota
通讯作者:
Londono, Maria-Carlota
影响因子:
3.1
作者:
Beinhardt, Sandra;Al Zoairy, Ramona;Maieron, Andreas
通讯作者:
Maieron, Andreas